Novo Nordisk AS (CHIX:NOVOBC) Total Tax Payable : kr9,716 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Novo Nordisk AS Total Tax Payable?

Novo Nordisk AS's Total Tax Payable for the quarter that ended in Dec. 2024 was kr9,716 Mil.

Novo Nordisk AS's quarterly Total Tax Payable increased from Jun. 2024 (kr5,906 Mil) to Sep. 2024 (kr14,651 Mil) but then declined from Sep. 2024 (kr14,651 Mil) to Dec. 2024 (kr9,716 Mil).

Novo Nordisk AS's annual Total Tax Payable increased from Dec. 2022 (kr7,091 Mil) to Dec. 2023 (kr7,116 Mil) and increased from Dec. 2023 (kr7,116 Mil) to Dec. 2024 (kr9,716 Mil).

Novo Nordisk AS Total Tax Payable Historical Data

The historical data trend for Novo Nordisk AS's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Total Tax Payable Chart

Novo Nordisk AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Tax Payable

Get a 7-Day Free Trial

3,913.00

3,658.00

7,091.00

7,116.00

9,716.00

Novo Nordisk AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Tax Payable	Get a 7-Day Free Trial															7,116.00	5,964.00	5,906.00	14,651.00	9,716.00

Novo Nordisk AS Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Novo Nordisk AS Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (CHIX:NOVOBc) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico 0TDD:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany NVON:Canada N1VO34:Brazil NOV:Bulgaria NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines